Abstract
We report on a 10-year-old child with nephrotic syndrome who developed recurrent lymphomatoid papulosis (LYP) 60 months after the first episode of proteinuria. LYP appeared when the child was taking low-dose cyclosporin and disappeared after the drug was replaced by prednisone at doses utilized for nephrotic syndrome (2 mg/kg). During the tapering of steroids, when the child was treated with low-dose prednisone (0.2 mg/kg), both LYP and nephrotic syndrome started again and required the reintroduction of prednisone to restore a normal clinical situation. This is the first case of LYP occurring in concomitance and synchronous with nephrotic syndrome. LYP was unrelated to cyclosporin (second episode after its withdrawn) but preceded the recurrence of proteinuria, suggesting a relationship with the disease activity. Even though the etiology of LYP is, in this case, uncertain, it should be considered as a clinical association of nephrotic syndrome in children and also included among potential triggers of the disease.
This is a preview of subscription content, log in via an institution to check access.
References
Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164
Ahmed M, Solangi K, Abbi R, Adler S (1997) Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis. J Am Soc Nephrol 8:848–852
Stephan JL, Deschenes G, Perel Y, Bader-Meunier B, Brunat-Mentigny M, Lejars O, Lamagneres JP (1997) Nephrotic syndrome and Hodgkin’s disease in children: a report of five cases. Eur J Pediatr 156:239–242
Kramer P, Sizoo W, Twiss EE (1981) Nephrotic syndrome in Hodgkin’s disease. Report of five cases and review of the literature. Neth J Med 24:114–119
Plager J, Stutzman L (1971) Acute nephrotic syndrome as a manifestation of active Hodgkin’s Disease. Report of four cases and review of the literature. Am J Med 50:56–66
Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, Boue F, Nochy D, Brousse N, Delarue R, Remy P, Ronco P, Sahali D, Lang P, Hermine O (2006) Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int 69:2251–2260
Macaulay WL (1968) Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign–histologically malignant. Arch Dermatol 97:23–30
Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768–3785
DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME (1996) The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437–3441
Wood GS, Hardman DL, Boni R, Dummer R, Kim YH, Smoller BR, Takeshita M, Kikuchi M, Burg G (1996) Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin’s disease. Blood 88:1765–1770
Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME (1992) Hodgkin’s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115–1122
Bates WD, Gray DW, Dada MA, Chetty R, Gatter KC, Davies DR, Morris PJ (2003) Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol 56:439–446
Ravat FE, Spittle MF, Russell-Jones R (2006) Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol 54:668–675
Fletcher CL, Orchard GE, Hubbard V, Whittaker SJ, Edelson RL, Russell-Jones R (2004) CD30(+) cutaneous lymphoma in association with atopic eczema. Arch Dermatol 140:449–454
Grimbert P, Audard V, Remy P, Lang P, Sahali D (2003) Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 18:245–248
Kuppers R (2002) Molecular biology of Hodgkin’s lymphoma. Adv Cancer Res 84:277–312
Sahali D, Pawlak A, Valanciute A, Grimbert P, Lang P, Remy P, Bensman A, Guellaen G (2002) A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13:1238–1247
Skinnider BF, Mak TW (2002) The role of cytokines in classical Hodgkin’s lymphoma. Blood 99:4283–4297
Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529–537
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghiggeri, G.M., Bleid, D., Garaventa, A. et al. Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin. Pediatr Nephrol 24, 189–192 (2009). https://doi.org/10.1007/s00467-007-0667-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0667-z